Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
| Brand name | CARBAMAZEPINE |
| Generic name | CARBAMAZEPINE |
| Active ingredient(s) | CARBAMAZEPINE |
| Distributed by / for | Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532 |
| NDC | 51672-4005-3 |
| Full product label | Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | US Nationwide. |
| Quantity | 1968 Bottles (1000Tablets/Bottle) |
| Recall initiated | 2026-08-03 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0770-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗